Novartis sells off blood diagnostics division


Swiss-based company Novartis has agreed to sell off its blood transfusion diagnostics unit to Spanish blood products specialist Grifols for $1.7 billion (£1 billion). The sale will allow the company to ‘focus more sharply on [its] strategic businesses’, according to chief executive Joseph Jimenez.

Novartis acquired the blood diagnostics unit when it bought Chiron in 2006. The main point of that acquisition was to kick start their vaccine development programme. Novartis has since developed new influenza vaccines that can be produced faster than methods based on chicken eggs, for example.


Related Content

Novartis in the spotlight in mis-selling investigations

9 January 2014 Business

news image

Crackdown on pharma marketing continues with US and Japanese cases

$25bn-plus trade sharpens pharma giants’ focus

25 April 2014 Business

news image

Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process

Most Read

Infrared camouflage that sticks

19 February 2015 Research

news image

Nature’s masters of disguise, the cephalopods, inspire inexpensive and disposable stealth coating that could easily be adde...

Nanoporous methane storage – an impossible target?

18 February 2015 Research

news image

Identifying performance limits for nanoporous materials highlights that current methane storage goals might be unrealistic

Most Commented

Nanoporous methane storage – an impossible target?

18 February 2015 Research

news image

Identifying performance limits for nanoporous materials highlights that current methane storage goals might be unrealistic

Enthralled by evaporation

20 February 2015 Organic Matter

news image

A giant rotary evaporator is a mesmerising thing, says Chemjobber, but the plant requires a different approach